Thyroxine-binding globulin inducers

DBCAT004602Pharmacologic class

Drugs that increase the plasma concentration of TGB. A DrugBank category of 25 drugs. 24 of them are approved.

Drugs: 5-fluorouridine
Clofibrate
Conjugated estrogens
Diamorphine
Diethylstilbestrol
Esterified estrogens
Estradiol
Estradiol acetate
Estradiol cypionate
Estradiol valerate
Estriol
Estrone
Estrone sulfate
Ethinylestradiol
Floxuridine
Fluorouracil
Hexestrol
Mestranol
Methadone
Mitotane
Quinestrol
Synthetic Conjugated Estrogens, A
Synthetic Conjugated Estrogens, B
Tamoxifen
Tegafur

What you can answer from here — as of March 05, 2019

25DrugsEach linked to its full drug card

Listed above

45Drug targetsEvery drug–target pair in the class, with bond type

4,453Marketed productsAcross the regions we cover, with dosage forms and routes

13Routes of administrationHow the drugs in this class are given

Which targets do Thyroxine-binding globulin inducers share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In